Literature DB >> 19023310

Angiotensin converting enzyme inhibitors and delayed onset, recurrent angioedema of the head and neck.

Y S Wakefield1, E D Theaker, M N Pemberton.   

Abstract

Angiotensin converting enzyme (ACE) inhibitors are a commonly prescribed, effective medication in the treatment of hypertension and heart failure. Several side-effects of dental relevance can occur including angioedema of the lips, mouth and throat. This adverse effect is well reported and can be fatal, but it is not always recognised by clinicians, as the angioedema does not always have a clear relationship with the commencement of the medication. The cases of angioedema reported here all presented in a dental setting and highlight both the delayed onset and the chronic recurrent nature of ACE inhibitor induced angioedema.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023310     DOI: 10.1038/sj.bdj.2008.982

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  4 in total

1.  A case report looking at ACE inhibitors as the cause of angioedema during dental treatment.

Authors:  P Raval
Journal:  Br Dent J       Date:  2014-01       Impact factor: 1.626

2.  Angioedema from instant coffee.

Authors:  Kelly J Larkin; Toban Dvoretzky; Nicholas J Solomos
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-07

3.  Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.

Authors:  M Wadelius; S E Marshall; G Islander; L Nordang; M Karawajczyk; Q-Y Yue; I Terreehorst; E V Baranova; S Hugosson; K Sköldefors; M Pirmohamed; A-H Maitland-van der Zee; A Alfirevic; P Hallberg; C N A Palmer
Journal:  Clin Pharmacol Ther       Date:  2014-06-24       Impact factor: 6.875

4.  ACE-Inhibitor Related Angioedema Is Not Sufficiently Reported to the Danish Adverse Drug Reactions Database.

Authors:  Johan Emil Lundbek Cornwall; Anette Bygum; Eva Rye Rasmussen
Journal:  Drug Healthc Patient Saf       Date:  2019-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.